![Jeff D. Edelson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff D. Edelson
Directeur Technique/Scientifique/R&D chez
BioMotiv LLC
Profil
Jeff D.
Edelson founded Aequanimitas Consulting LLC, where he worked as Principal.
Dr. Edelson also currently works at BioMotiv LLC, as Vice President-Clinical.
Dr. Edelson also formerly worked at Aventis, Inc., as Senior Director, Palatin Technologies, Inc., as Chief Medical Officer from 2010 to 2014, Ikano Therapeutics, Inc., as Chief Medical Officer & Executive Vice President from 2008 to 2011, the University of Pennsylvania, as Associate Professor, The Biotechnology Greenhouse Corp.
of Southeastern PA, as Scientific Liaison, GlaxoSmithKline, Inc., as Principal, Therion Biologics Corp., as Principal, and Johnson & Johnson Pharmaceutical Services LLC, as Head-Novel Therapeutics.
Dr. Edelson received his graduate degree and doctorate degree from the University of Toronto.
Postes actifs de Jeff D. Edelson
| Sociétés | Poste | Début |
|---|---|---|
BioMotiv LLC
 BioMotiv LLC BiotechnologyHealth Technology Operates as a research institution in the field of therapeutics | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Jeff D. Edelson
| Sociétés | Poste | Fin |
|---|---|---|
| PALATIN TECHNOLOGIES, INC. | Directeur Technique/Scientifique/R&D | 01/11/2014 |
Ikano Therapeutics, Inc.
 Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Technique/Scientifique/R&D | 18/01/2011 |
Aequanimitas Consulting LLC
 Aequanimitas Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic and operational product development services | Fondateur | - |
The Biotechnology Greenhouse Corp. of Southeastern PA
 The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance BioAdvance invests in companies located in the United States, primarily in New York and Washington, D.C. The firm targets companies operating in the fields of medical devices, digital health, diagnostics and research tools in healthcare sector. It provides financing for seed and early stage capital requirements with an investment size of USD 0.5 - 5 million and also acts as lead investor. | Private Equity Investor | - |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Formation de Jeff D. Edelson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Palatin Technologies, Inc.
 Palatin Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines based on molecules for the modulation of melanocortin receptor system | Health Technology |
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Ikano Therapeutics, Inc.
Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
BioMotiv LLC
BioMotiv LLC BiotechnologyHealth Technology Operates as a research institution in the field of therapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Biotechnology Greenhouse Corp. of Southeastern PA
The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance BioAdvance invests in companies located in the United States, primarily in New York and Washington, D.C. The firm targets companies operating in the fields of medical devices, digital health, diagnostics and research tools in healthcare sector. It provides financing for seed and early stage capital requirements with an investment size of USD 0.5 - 5 million and also acts as lead investor. | Finance |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Therion Biologics Corp.
 Therion Biologics Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic vaccines for cancer patients | Health Technology |
Johnson & Johnson Pharmaceutical Services LLC
 Johnson & Johnson Pharmaceutical Services LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aequanimitas Consulting LLC
Aequanimitas Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic and operational product development services | Commercial Services |
